Insider Transactions in Q4 2024 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2024
|
Marc Stapley Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,590
-0.89%
|
$240,370
$43.75 P/Share
|
|
Dec 04
2024
|
Annie Mc Guire SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
18,699
-20.42%
|
$822,756
$44.02 P/Share
|
|
Dec 04
2024
|
Phillip G. Febbo Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
3,934
-4.56%
|
$173,096
$44.09 P/Share
|
|
Dec 03
2024
|
Jonathan Wygant VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
956
-2.32%
|
$41,108
$43.36 P/Share
|
|
Dec 03
2024
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,000
-5.78%
|
$301,000
$43.23 P/Share
|
|
Dec 03
2024
|
John Leite Chief Commercial Officer-CLIA |
SELL
Open market or private sale
|
Direct |
1,050
-1.4%
|
$45,150
$43.25 P/Share
|
|
Dec 02
2024
|
Annie Mc Guire SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,918
-2.05%
|
$84,392
$44.12 P/Share
|
|
Dec 02
2024
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,748
-1.8%
|
$252,912
$44.12 P/Share
|
|
Dec 02
2024
|
Jonathan Wygant VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,087
-2.57%
|
$47,828
$44.12 P/Share
|
|
Dec 02
2024
|
Phillip G. Febbo Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,738
-7.24%
|
$296,472
$44.12 P/Share
|
|
Dec 02
2024
|
Rebecca Chambers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,464
-2.78%
|
$152,416
$44.12 P/Share
|
|
Dec 02
2024
|
John Leite Chief Commercial Officer-CLIA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,314
-1.73%
|
$57,816
$44.12 P/Share
|
|
Nov 27
2024
|
Jonathan Wygant VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,032
-10.63%
|
$211,344
$42.89 P/Share
|
|
Nov 19
2024
|
Karin Eastham Director |
SELL
Open market or private sale
|
Direct |
14,731
-16.56%
|
$545,047
$37.77 P/Share
|
|
Nov 12
2024
|
Robert S Epstein Director |
SELL
Open market or private sale
|
Direct |
15,000
-25.17%
|
$570,000
$38.32 P/Share
|
|
Nov 12
2024
|
Robert S Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.11%
|
$120,000
$8.04 P/Share
|
|
Nov 12
2024
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,275
-10.93%
|
$580,450
$38.34 P/Share
|